Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinical Trial Required

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider a single source application for the award of a grant to the Duke University’s Duke Translational Medicine Institute (DTMI) to support the Clinical Trials Transformation Initiative (CTTI).